Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 87 entries
Sorted by: Best Match Show Resources per page
Performance of Low-Dose Chest CT as a Triage Tool for Suspected COVID-19 Patients.

Journal of the Belgian Society of Radiology

Desmet J, Biebaû C, De Wever W, Cockmartin L, Viktor V, Coolen J, Verschakelen J, Dubbeldam A.
PMID: 33634237
J Belg Soc Radiol. 2021 Feb 16;105(1):9. doi: 10.5334/jbsr.2319.

PURPOSE: To investigate the role of low-dose chest computed tomography (CT) imaging in the triage of patients suspected of coronavirus disease 2019 (COVID-19) in an emergency setting.MATERIALS AND METHODS: Data from 610 patients admitted to our emergency unit from...

Cite
Desmet J, Biebaû C, De Wever W, et al. Performance of Low-Dose Chest CT as a Triage Tool for Suspected COVID-19 Patients. J Belg Soc Radiol. 2021;105(1):9doi: 10.5334/jbsr.2319.
Desmet, J., Biebaû, C., De Wever, W., Cockmartin, L., Viktor, V., Coolen, J., Verschakelen, J., & Dubbeldam, A. (2021). Performance of Low-Dose Chest CT as a Triage Tool for Suspected COVID-19 Patients. Journal of the Belgian Society of Radiology, 105(1), 9. https://doi.org/10.5334/jbsr.2319
Desmet, Jeroen, et al. "Performance of Low-Dose Chest CT as a Triage Tool for Suspected COVID-19 Patients." Journal of the Belgian Society of Radiology vol. 105,1 (2021): 9. doi: https://doi.org/10.5334/jbsr.2319
Desmet J, Biebaû C, De Wever W, Cockmartin L, Viktor V, Coolen J, Verschakelen J, Dubbeldam A. Performance of Low-Dose Chest CT as a Triage Tool for Suspected COVID-19 Patients. J Belg Soc Radiol. 2021 Feb 16;105(1):9. doi: 10.5334/jbsr.2319. PMID: 33634237; PMCID: PMC7894373.
Copy Download .nbib Format: NLM
Prognostic value of the Surprise Question for one-year mortality in older patients: a prospective multicenter study in acute geriatric and cardiology units.

Acta clinica Belgica

Maes H, Van Den Noortgate N, De Brauwer I, Velghe A, Desmedt M, De Saint-Hubert M, Piers R.
PMID: 33044915
Acta Clin Belg. 2020 Oct 12;1-9. doi: 10.1080/17843286.2020.1829869. Epub 2020 Oct 12.

OBJECTIVES: To determine the prognostic value of the Surprise Question (SQ) in older persons.METHODS: A multicenter prospective study, including patients aged 75 years or older admitted to acute geriatric (AGU) or cardiology unit (CU). The SQ was answered by...

Cite
Maes H, Van Den Noortgate N, De Brauwer I, et al. Prognostic value of the Surprise Question for one-year mortality in older patients: a prospective multicenter study in acute geriatric and cardiology units. Acta Clin Belg. 2020;1-9doi: 10.1080/17843286.2020.1829869.
Maes, H., Van Den Noortgate, N., De Brauwer, I., Velghe, A., Desmedt, M., De Saint-Hubert, M., & Piers, R. (2020). Prognostic value of the Surprise Question for one-year mortality in older patients: a prospective multicenter study in acute geriatric and cardiology units. Acta clinica Belgica, 1-9. https://doi.org/10.1080/17843286.2020.1829869
Maes, Hanne, et al. "Prognostic value of the Surprise Question for one-year mortality in older patients: a prospective multicenter study in acute geriatric and cardiology units." Acta clinica Belgica vol. (2020): 1-9. doi: https://doi.org/10.1080/17843286.2020.1829869
Maes H, Van Den Noortgate N, De Brauwer I, Velghe A, Desmedt M, De Saint-Hubert M, Piers R. Prognostic value of the Surprise Question for one-year mortality in older patients: a prospective multicenter study in acute geriatric and cardiology units. Acta Clin Belg. 2020 Oct 12;1-9. doi: 10.1080/17843286.2020.1829869. Epub 2020 Oct 12. PMID: 33044915.
Copy Download .nbib Format: NLM
Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis.

Neurobiology of disease

Bourel J, Planche V, Dubourdieu N, Oliveira A, Séré A, Ducourneau EG, Tible M, Maitre M, Lesté-Lasserre T, Nadjar A, Desmedt A, Ciofi P, Oliet SH, Panatier A, Tourdias T.
PMID: 34673149
Neurobiol Dis. 2021 Dec;160:105533. doi: 10.1016/j.nbd.2021.105533. Epub 2021 Oct 19.

Memory impairment is one of the disabling manifestations of multiple sclerosis (MS) possibly present from the early stages of the disease and for which there is no specific treatment. Hippocampal synaptic dysfunction and dendritic loss, associated with microglial activation,...

Cite
Bourel J, Planche V, Dubourdieu N, et al. Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis. Neurobiol Dis. 2021;160:105533doi: 10.1016/j.nbd.2021.105533.
Bourel, J., Planche, V., Dubourdieu, N., Oliveira, A., Séré, A., Ducourneau, E. G., Tible, M., Maitre, M., Lesté-Lasserre, T., Nadjar, A., Desmedt, A., Ciofi, P., Oliet, S. H., Panatier, A., & Tourdias, T. (2021). Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis. Neurobiology of disease, 160105533. https://doi.org/10.1016/j.nbd.2021.105533
Bourel, Julien, et al. "Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis." Neurobiology of disease vol. 160 (2021): 105533. doi: https://doi.org/10.1016/j.nbd.2021.105533
Bourel J, Planche V, Dubourdieu N, Oliveira A, Séré A, Ducourneau EG, Tible M, Maitre M, Lesté-Lasserre T, Nadjar A, Desmedt A, Ciofi P, Oliet SH, Panatier A, Tourdias T. Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis. Neurobiol Dis. 2021 Dec;160:105533. doi: 10.1016/j.nbd.2021.105533. Epub 2021 Oct 19. PMID: 34673149.
Copy Download .nbib Format: NLM
Cell-penetrating Alphabody protein scaffolds for intracellular drug targeting.

Science advances

Pannecoucke E, Van Trimpont M, Desmet J, Pieters T, Reunes L, Demoen L, Vuylsteke M, Loverix S, Vandenbroucke K, Alard P, Henderikx P, Deroo S, Baatz F, Lorent E, Thiolloy S, Somers K, McGrath Y, Van Vlierberghe P, Lasters I, Savvides SN.
PMID: 33771865
Sci Adv. 2021 Mar 26;7(13). doi: 10.1126/sciadv.abe1682. Print 2021 Mar.

The therapeutic scope of antibody and nonantibody protein scaffolds is still prohibitively limited against intracellular drug targets. Here, we demonstrate that the Alphabody scaffold can be engineered into a cell-penetrating protein antagonist against induced myeloid leukemia cell differentiation protein...

Cite
Pannecoucke E, Van Trimpont M, Desmet J, et al. Cell-penetrating Alphabody protein scaffolds for intracellular drug targeting. Sci Adv. 2021;7(13)doi: 10.1126/sciadv.abe1682.
Pannecoucke, E., Van Trimpont, M., Desmet, J., Pieters, T., Reunes, L., Demoen, L., Vuylsteke, M., Loverix, S., Vandenbroucke, K., Alard, P., Henderikx, P., Deroo, S., Baatz, F., Lorent, E., Thiolloy, S., Somers, K., McGrath, Y., Van Vlierberghe, P., Lasters, I., & Savvides, S. N. (2021). Cell-penetrating Alphabody protein scaffolds for intracellular drug targeting. Science advances, 7(13), . https://doi.org/10.1126/sciadv.abe1682
Pannecoucke, Erwin, et al. "Cell-penetrating Alphabody protein scaffolds for intracellular drug targeting." Science advances vol. 7,13 (2021). doi: https://doi.org/10.1126/sciadv.abe1682
Pannecoucke E, Van Trimpont M, Desmet J, Pieters T, Reunes L, Demoen L, Vuylsteke M, Loverix S, Vandenbroucke K, Alard P, Henderikx P, Deroo S, Baatz F, Lorent E, Thiolloy S, Somers K, McGrath Y, Van Vlierberghe P, Lasters I, Savvides SN. Cell-penetrating Alphabody protein scaffolds for intracellular drug targeting. Sci Adv. 2021 Mar 26;7(13). doi: 10.1126/sciadv.abe1682. Print 2021 Mar. PMID: 33771865; PMCID: PMC7997521.
Copy Download .nbib Format: NLM
Ten-year outcomes after primary vertical sleeve gastrectomy for morbid obesity: a monocentric cohort study.

Surgical endoscopy

Hauters P, Dubart JW, Desmet J, Degolla R, Roumain M, Malvaux P.
PMID: 33140154
Surg Endosc. 2021 Dec;35(12):6466-6471. doi: 10.1007/s00464-020-08137-8. Epub 2020 Nov 02.

OBJECTIVE: To assess the 10-year outcomes after sleeve gastrectomy (SG). Primary end-points were the long-term weight loss and the need for conversion and one of the secondary end-points was the incidence of gastroesophageal reflux (GERD).MATERIALS AND METHODS: Between 2006...

Cite
Hauters P, Dubart JW, Desmet J, et al. Ten-year outcomes after primary vertical sleeve gastrectomy for morbid obesity: a monocentric cohort study. Surg Endosc. 2020;35(12):6466-6471doi: 10.1007/s00464-020-08137-8.
Hauters, P., Dubart, J. W., Desmet, J., Degolla, R., Roumain, M., & Malvaux, P. (2021). Ten-year outcomes after primary vertical sleeve gastrectomy for morbid obesity: a monocentric cohort study. Surgical endoscopy, 35(12), 6466-6471. https://doi.org/10.1007/s00464-020-08137-8
Hauters, P, et al. "Ten-year outcomes after primary vertical sleeve gastrectomy for morbid obesity: a monocentric cohort study." Surgical endoscopy vol. 35,12 (2021): 6466-6471. doi: https://doi.org/10.1007/s00464-020-08137-8
Hauters P, Dubart JW, Desmet J, Degolla R, Roumain M, Malvaux P. Ten-year outcomes after primary vertical sleeve gastrectomy for morbid obesity: a monocentric cohort study. Surg Endosc. 2021 Dec;35(12):6466-6471. doi: 10.1007/s00464-020-08137-8. Epub 2020 Nov 02. PMID: 33140154.
Copy Download .nbib Format: NLM
How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer Research.

Cancers

Pate L, Desmedt C, Metzger O, Burgess Hutcheson L, Turner C, Freeney S, Oesterreich S.
PMID: 34206261
Cancers (Basel). 2021 Jun 22;13(13). doi: 10.3390/cancers13133094.

Breast cancer research and therapies have significantly advanced in recent years. However, Invasive Lobular Carcinoma (ILC), the second most common histological type of breast cancer and the sixth most frequently diagnosed cancer of women, has not always benefited from...

Cite
Pate L, Desmedt C, Metzger O, et al. How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer Research. Cancers (Basel). 2021;13(13)doi: 10.3390/cancers13133094.
Pate, L., Desmedt, C., Metzger, O., Burgess Hutcheson, L., Turner, C., Freeney, S., & Oesterreich, S. (2021). How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer Research. Cancers, 13(13), . https://doi.org/10.3390/cancers13133094
Pate, Leigh, et al. "How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer Research." Cancers vol. 13,13 (2021). doi: https://doi.org/10.3390/cancers13133094
Pate L, Desmedt C, Metzger O, Burgess Hutcheson L, Turner C, Freeney S, Oesterreich S. How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer Research. Cancers (Basel). 2021 Jun 22;13(13). doi: 10.3390/cancers13133094. PMID: 34206261; PMCID: PMC8268486.
Copy Download .nbib Format: NLM
Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial.

Clinical breast cancer

Caparica R, Ma Y, De Angelis C, Richard F, Desmedt C, Awada A, Piccart M, Perez EA, Moreno-Aspitia A, Badve S, Thompson EA, de Azambuja E.
PMID: 34980541
Clin Breast Cancer. 2021 Dec 02; doi: 10.1016/j.clbc.2021.11.012. Epub 2021 Dec 02.

BACKGROUND: Beta-2 adrenergic receptor (ß2AR) modulates immune activation and may enhance trastuzumab activity. We assessed the impact of ß2AR gene (ADRB2) expression on the outcomes of patients with HER2-positive early-stage breast cancer enrolled on the NCCTG-N9831 trial.PATIENTS AND METHODS:...

Cite
Caparica R, Ma Y, De Angelis C, et al. Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial. Clin Breast Cancer. 2021;doi: 10.1016/j.clbc.2021.11.012.
Caparica, R., Ma, Y., De Angelis, C., Richard, F., Desmedt, C., Awada, A., Piccart, M., Perez, E. A., Moreno-Aspitia, A., Badve, S., Thompson, E. A., & de Azambuja, E. (2021). Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial. Clinical breast cancer, . https://doi.org/10.1016/j.clbc.2021.11.012
Caparica, Rafael, et al. "Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial." Clinical breast cancer vol. (2021). doi: https://doi.org/10.1016/j.clbc.2021.11.012
Caparica R, Ma Y, De Angelis C, Richard F, Desmedt C, Awada A, Piccart M, Perez EA, Moreno-Aspitia A, Badve S, Thompson EA, de Azambuja E. Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial. Clin Breast Cancer. 2021 Dec 02; doi: 10.1016/j.clbc.2021.11.012. Epub 2021 Dec 02. PMID: 34980541.
Copy Download .nbib Format: NLM
Water dynamics in hardened ordinary Portland cement paste or concrete: from quasielastic neutron scattering.

The journal of physical chemistry. B

Bordallo HN, Aldridge LP, Desmedt A.
PMID: 16956288
J Phys Chem B. 2006 Sep 14;110(36):17966-76. doi: 10.1021/jp062922f.

Portland cement reacts with water to form an amorphous paste through a chemical reaction called hydration. In concrete the formation of pastes causes the mix to harden and gain strength to form a rock-like mass. Within this process lies...

Cite
Bordallo HN, Aldridge LP, Desmedt A. Water dynamics in hardened ordinary Portland cement paste or concrete: from quasielastic neutron scattering. J Phys Chem B. 2006;110(36):17966-76doi: 10.1021/jp062922f.
Bordallo, H. N., Aldridge, L. P., & Desmedt, A. (2006). Water dynamics in hardened ordinary Portland cement paste or concrete: from quasielastic neutron scattering. The journal of physical chemistry. B, 110(36), 17966-76. https://doi.org/10.1021/jp062922f
Bordallo, Heloisa N, et al. "Water dynamics in hardened ordinary Portland cement paste or concrete: from quasielastic neutron scattering." The journal of physical chemistry. B vol. 110,36 (2006): 17966-76. doi: https://doi.org/10.1021/jp062922f
Bordallo HN, Aldridge LP, Desmedt A. Water dynamics in hardened ordinary Portland cement paste or concrete: from quasielastic neutron scattering. J Phys Chem B. 2006 Sep 14;110(36):17966-76. doi: 10.1021/jp062922f. PMID: 16956288.
Copy Download .nbib Format: NLM
Enhancement of the Raman scattering signal due to a nanolens effect.

Applied spectroscopy

Desmedt A, Talaga D, Bruneel JL.
PMID: 17650373
Appl Spectrosc. 2007 Jun;61(6):621-3. doi: 10.1366/000370207781269837.

The Raman scattering signal of a substrate is investigated using a polystyrene nanolens of a few hundred nanometers inserted within the light path of a confocal microspectrometer. As observed in solid immersion microscopy, the nanolens is at the origin...

Cite
Desmedt A, Talaga D, Bruneel JL. Enhancement of the Raman scattering signal due to a nanolens effect. Appl Spectrosc. 2007;61(6):621-3doi: 10.1366/000370207781269837.
Desmedt, A., Talaga, D., & Bruneel, J. L. (2007). Enhancement of the Raman scattering signal due to a nanolens effect. Applied spectroscopy, 61(6), 621-3. https://doi.org/10.1366/000370207781269837
Desmedt, A, et al. "Enhancement of the Raman scattering signal due to a nanolens effect." Applied spectroscopy vol. 61,6 (2007): 621-3. doi: https://doi.org/10.1366/000370207781269837
Desmedt A, Talaga D, Bruneel JL. Enhancement of the Raman scattering signal due to a nanolens effect. Appl Spectrosc. 2007 Jun;61(6):621-3. doi: 10.1366/000370207781269837. PMID: 17650373.
Copy Download .nbib Format: NLM
Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer.

Breast cancer research and treatment

Rothschild HT, Abel MK, Patterson A, Goodman K, Shui A, van Baelen K, Desmedt C, Benz C, Mukhtar RA.
PMID: 34817747
Breast Cancer Res Treat. 2022 Jan;191(2):451-458. doi: 10.1007/s10549-021-06453-8. Epub 2021 Nov 24.

PURPOSE: We investigated the relationship between obesity, menopausal status, and invasive lobular carcinoma (ILC), the second most common histological subtype of breast cancer. Specifically, we evaluated the association between body mass index (BMI), metabolic syndrome, the 21-gene Oncotype Recurrence...

Cite
Rothschild HT, Abel MK, Patterson A, et al. Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer. Breast Cancer Res Treat. 2021;191(2):451-458doi: 10.1007/s10549-021-06453-8.
Rothschild, H. T., Abel, M. K., Patterson, A., Goodman, K., Shui, A., van Baelen, K., Desmedt, C., Benz, C., & Mukhtar, R. A. (2022). Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer. Breast cancer research and treatment, 191(2), 451-458. https://doi.org/10.1007/s10549-021-06453-8
Rothschild, Harriet T, et al. "Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer." Breast cancer research and treatment vol. 191,2 (2022): 451-458. doi: https://doi.org/10.1007/s10549-021-06453-8
Rothschild HT, Abel MK, Patterson A, Goodman K, Shui A, van Baelen K, Desmedt C, Benz C, Mukhtar RA. Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer. Breast Cancer Res Treat. 2022 Jan;191(2):451-458. doi: 10.1007/s10549-021-06453-8. Epub 2021 Nov 24. PMID: 34817747.
Copy Download .nbib Format: NLM
The dynamical properties of the aromatic hydrogen bond in NH4(C6H5)4B from quasielastic neutron scattering.

The Journal of chemical physics

Jalarvo N, Desmedt A, Lechner RE, Mezei F.
PMID: 17115771
J Chem Phys. 2006 Nov 14;125(18):184513. doi: 10.1063/1.2374888.

NH(4)(C(6)H(5))(4)B represents a prototypical system for understanding aromatic H bonds. In NH(4)(C(6)H(5))(4)B an ammonium cation is trapped in an aromatic cage of four phenyl rings and each phenyl ring serves as a hydrogen bond acceptor for the ammonium ion...

Cite
Jalarvo N, Desmedt A, Lechner RE, et al. The dynamical properties of the aromatic hydrogen bond in NH4(C6H5)4B from quasielastic neutron scattering. J Chem Phys. 2006;125(18):184513doi: 10.1063/1.2374888.
Jalarvo, N., Desmedt, A., Lechner, R. E., & Mezei, F. (2006). The dynamical properties of the aromatic hydrogen bond in NH4(C6H5)4B from quasielastic neutron scattering. The Journal of chemical physics, 125(18), 184513. https://doi.org/10.1063/1.2374888
Jalarvo, Niina, et al. "The dynamical properties of the aromatic hydrogen bond in NH4(C6H5)4B from quasielastic neutron scattering." The Journal of chemical physics vol. 125,18 (2006): 184513. doi: https://doi.org/10.1063/1.2374888
Jalarvo N, Desmedt A, Lechner RE, Mezei F. The dynamical properties of the aromatic hydrogen bond in NH4(C6H5)4B from quasielastic neutron scattering. J Chem Phys. 2006 Nov 14;125(18):184513. doi: 10.1063/1.2374888. PMID: 17115771.
Copy Download .nbib Format: NLM
Correction to: Long-term hearing results of stapedotomy: analysis of factors affecting outcome.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Dhooge I, Desmedt S, Maly T, Loose D, Van Hoecke H.
PMID: 29549428
Eur Arch Otorhinolaryngol. 2018 May;275(5):1121. doi: 10.1007/s00405-018-4927-2.

The given and family names of all the co-authors are incorrect in the published article. The correct names should read as follows.

Cite
Dhooge I, Desmedt S, Maly T, et al. Correction to: Long-term hearing results of stapedotomy: analysis of factors affecting outcome. Eur Arch Otorhinolaryngol. 2018;275(5):1121doi: 10.1007/s00405-018-4927-2.
Dhooge, I., Desmedt, S., Maly, T., Loose, D., & Van Hoecke, H. (2018). Correction to: Long-term hearing results of stapedotomy: analysis of factors affecting outcome. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 275(5), 1121. https://doi.org/10.1007/s00405-018-4927-2
Dhooge, Ingeborg, et al. "Correction to: Long-term hearing results of stapedotomy: analysis of factors affecting outcome." European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery vol. 275,5 (2018): 1121. doi: https://doi.org/10.1007/s00405-018-4927-2
Dhooge I, Desmedt S, Maly T, Loose D, Van Hoecke H. Correction to: Long-term hearing results of stapedotomy: analysis of factors affecting outcome. Eur Arch Otorhinolaryngol. 2018 May;275(5):1121. doi: 10.1007/s00405-018-4927-2. PMID: 29549428.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 87 entries